Immunocan Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $36.7M

  • Investors
  • 3

Immunocan General Information

Description

Manufacturer of biotechnology products intended to support biomedical research and healthcare applications. The company offers biological reagents, laboratory testing services, and technical development capabilities, enabling research institutions and healthcare organizations to improve experimental accuracy and advance life science studies.

Contact Information

Website
www.immunocan.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Building 1
  • Number 398 Xinlai Road, Jiading District
  • Shanghai, 200000
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 5th Floor, Building 1
  • Number 398 Xinlai Road, Jiading District
  • Shanghai, 200000
  • China
+86 021

Immunocan Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunocan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 13-May-2026 $36.7M Completed Generating Revenue
3. Early Stage VC 08-Aug-2023 Completed Generating Revenue
2. Early Stage VC 06-Feb-2022 $7.71M Completed Generating Revenue
1. Early Stage VC 16-Aug-2021 $7.71M $7.71M Completed Generating Revenue
To view Immunocan’s complete valuation and funding history, request access »

Immunocan Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Vivo Capital Venture Capital Minority
Beijing Xicheng Jinrui Equity Investment Fund Management Venture Capital Minority
TigerYeah Capital Venture Capital Minority
To view Immunocan’s complete investors history, request access »

Ready to get started?

Request a free trial

Immunocan FAQs

  • When was Immunocan founded?

    Immunocan was founded in 2020.

  • Where is Immunocan headquartered?

    Immunocan is headquartered in Shanghai, China.

  • What industry is Immunocan in?

    Immunocan’s primary industry is Biotechnology.

  • Is Immunocan a private or public company?

    Immunocan is a Private company.

  • What is Immunocan’s current revenue?

    The current revenue for Immunocan is .

  • How much funding has Immunocan raised over time?

    Immunocan has raised $44.4M.

  • Who are Immunocan’s investors?

    Vivo Capital, Beijing Xicheng Jinrui Equity Investment Fund Management, and TigerYeah Capital have invested in Immunocan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process